Articles with public access mandates - John Strang - National Health and Medical Research Council, AustraliaLearn more
NoteFor this mandate, articles should be available from specific locations.
Not available based on mandate: 1
Prevention, early intervention, harm reduction, and treatment of substance use in young people
E Stockings, WD Hall, M Lynskey, KI Morley, N Reavley, J Strang, ...
The Lancet Psychiatry 3 (3), 280-296, 2016
Available based on mandate: 12
Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label …
C Rodgers, KJ Siefried, A Ritter, V Belackova, C Treloar, M Jauncey, ...
BMJ open 14 (8), e082553, 2024
Understanding preferences for type of take-home naloxone device: international qualitative analysis of the views of people who use opioids
J Neale, A Farrugia, AN Campbell, P Dietze, R Dwyer, R Fomiatti, ...
Drugs: Education, Prevention and Policy 29 (2), 109-120, 2022
Global opioid agonist treatment: a review of clinical practices by country
H Jin, BDL Marshall, L Degenhardt, J Strang, M Hickman, DA Fiellin, R Ali, ...
Addiction 115 (12), 2243-2254, 2020
Take-home naloxone for the emergency interim management of opioid overdose: the public health application of an emergency medicine
J Strang, R McDonald, G Campbell, L Degenhardt, S Nielsen, A Ritter, ...
Drugs 79, 1395-1418, 2019
Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: trivariate twin modelling and implications for genetic design
LA Hines, KI Morley, F Rijsdijk, J Strang, A Agrawal, EC Nelson, ...
Psychological medicine 48 (16), 2786-2793, 2018
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
S Larney, A Peacock, J Leung, S Colledge, M Hickman, P Vickerman, ...
The Lancet Global Health 5 (12), e1208-e1220, 2017
A mapping review of take-home naloxone for people released from correctional settings
M Horton, R McDonald, TC Green, S Nielsen, J Strang, L Degenhardt, ...
International Journal of Drug Policy 46, 7-16, 2017
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013
L Degenhardt, F Charlson, J Stanaway, S Larney, LT Alexander, ...
The Lancet infectious diseases 16 (12), 1385-1398, 2016
Onset of opportunity to use cannabis and progression from opportunity to dependence: Are influences consistent across transitions?
LA Hines, KI Morley, J Strang, A Agrawal, EC Nelson, D Statham, ...
Drug and alcohol dependence 160, 57-64, 2016
Onset of opportunity to use cannabis and progression
LAHKI Morley, J Strang
J. Stud. Alcohol Drugs 55, 149, 2016
The association between speed of transition from initiation to subsequent use of cannabis and later problematic cannabis use, abuse and dependence
LA Hines, KI Morley, J Strang, A Agrawal, EC Nelson, D Statham, ...
Addiction 110 (8), 1311-1320, 2015
Alcohol harm reduction: corporate capture of a key concept
J McCambridge, K Kypri, C Drummond, J Strang
PLoS Medicine 11 (12), e1001767, 2014
Publication and funding information is determined automatically by a computer program